1
|
Farag YG, Hanafi RS, Hammam MA. Novel dummy molecularly imprinted polymer for simultaneous solid-phase extraction of stanozolol metabolites from urine. Anal Bioanal Chem 2024; 416:3335-3347. [PMID: 38661944 PMCID: PMC11106188 DOI: 10.1007/s00216-024-05285-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2024] [Revised: 03/20/2024] [Accepted: 03/25/2024] [Indexed: 04/26/2024]
Abstract
Stanozolol, a synthetic derivative of testosterone, is one of the common doping drugs among athletes and bodybuilders. It is metabolized to a large extent and metabolites are detected in urine for a longer duration than the parent compound. In this study, a novel dummy molecularly imprinted polymer (DMIP) is developed as a sorbent for solid-phase extraction of stanozolol metabolites from spiked human urine samples. The optimized DMIP is composed of stanozolol as the dummy template, methacrylic acid as the functional monomer, and ethylene glycol dimethacrylate as the cross-linker in a ratio of 1:10:80. The extracted analytes were quantitively determined using a newly developed and validated ultrahigh-performance liquid chromatography tandem mass spectrometry method, where the limits of detection and quantitation were 0.91 and 1.81 ng mL-1, respectively, fulfilling the minimum required performance limit decided on by the World Anti-Doping Agency. The mean percentage extraction recoveries for 3'-hydroxystanozolol, 4β-hydroxystanozolol, and 16β-hydroxystanozolol are 97.80% ± 13.80, 83.16% ± 7.50, and 69.98% ± 2.02, respectively. As such, the developed DMISPE can serve as an efficient cost-effective tool for doping and regulatory agencies for simultaneous clean-up of the stanozolol metabolites prior to their quantification.
Collapse
Affiliation(s)
- Yomna G Farag
- Pharmaceutical Chemistry Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, 11835, Egypt
| | - Rasha S Hanafi
- Pharmaceutical Chemistry Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, 11835, Egypt.
| | - Mennatallah A Hammam
- Pharmaceutical Chemistry Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, 11835, Egypt
- Department of Chemistry, School of Life and Medical Sciences, University of Hertfordshire Hosted By Global Academic Foundation, New Administrative Capital, Cairo, 4813001, Egypt
| |
Collapse
|
2
|
Investigations into the concentration and metabolite profiles of stanozolol and LGD-4033 in blood plasma and seminal fluid using liquid chromatography high-resolution mass spectrometry. Anal Bioanal Chem 2023; 415:669-681. [PMID: 36441233 PMCID: PMC9839828 DOI: 10.1007/s00216-022-04456-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Revised: 10/27/2022] [Accepted: 11/21/2022] [Indexed: 11/29/2022]
Abstract
Potential scenarios as to the origin of minute amounts of banned substances detected in doping control samples have been a much-discussed problem in anti-doping analysis in recent years. One such debated scenario has been the contamination of female athletes' urine with ejaculate containing doping agents and/or their metabolites. The aim of this work was to obtain complementary information on whether relevant concentration ranges of doping substances are excreted into the ejaculate and which metabolites can be detected in the seminal fluid (sf) and corresponding blood plasma (bp) samples. A method was established to study the concentration and metabolite profiles of stanozolol and LGD-4033-substances listed under anabolic substances (S1) on the World Anti-Doping Agency's Prohibited List-in bp and sf using liquid chromatography high-resolution mass spectrometry (LC-HRMS). For sf and bp, methods for detecting minute amounts of these substances were developed and tested for specificity, recovery, linearity, precision, and reliability. Subsequently, sf and bp samples from an animal administration study, where a boar orally received stanozolol at 0.33 mg/kg and LGD-4033 at 0.11 mg/kg, were measured. The developed assays proved appropriate for the detection of the target substances in both matrices with detection limits between 10 and 40 pg/mL for the unmetabolized drugs in sf and bp, allowing to estimate the concentration of stanozolol in bp (0.02-0.40 ng/mL) and in sf (0.01-0.25 ng/mL) as well as of LGD-4033 in bp (0.21-2.00 ng/mL) and in sf (0.03-0.68 ng/mL) post-administration. In addition, metabolites resulting from different metabolic pathways were identified in sf and bp, with sf resembling a composite of the metabolic profile of bp and urine.
Collapse
|
3
|
Interest of HRMS systems in analytical toxicology: Focus on doping products. TOXICOLOGIE ANALYTIQUE ET CLINIQUE 2022. [DOI: 10.1016/j.toxac.2021.10.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
4
|
Göschl L, Gmeiner G, Gärtner P, Stadler G, Enev V, Thevis M, Schänzer W, Guddat S, Forsdahl G. Stanozolol-N-glucuronide metabolites in human urine samples as suitable targets in terms of routine anti-doping analysis. Drug Test Anal 2021; 13:1668-1677. [PMID: 34089570 DOI: 10.1002/dta.3109] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2021] [Revised: 06/01/2021] [Accepted: 06/03/2021] [Indexed: 02/01/2023]
Abstract
The exogenous anabolic-androgenic steroid (AAS) stanozolol stays one of the most detected substances in professional sports. Its detection is a fundamental part of doping analysis, and the analysis of this steroid has been intensively investigated for a long time. This contribution to the detection of stanozolol doping describes for the first time the unambiguous proof for the existence of 17-epistanozolol-1'N-glucuronide and 17-epistanozolol-2'N-glucuronide in stanozolol-positive human urine samples due to the access to high-quality reference standards. Examination of excretion study samples shows large detection windows for the phase-II metabolites stanozolol-1'N-glucuronide and 17-epistanozolol-1'N-glucuronide up to 12 days and respectively up to almost 28 days. In addition, we present appropriate validation parameters for the analysis of these metabolites using a fully automatic method online solid-phase extraction (SPE) method already published before. Limits of identification (LOIs) as low as 100 pg/ml and other validation parameters like accuracy, precision, sensitivity, robustness, and linearity are given.
Collapse
Affiliation(s)
- Lorenz Göschl
- Doping Control Laboratory, Seibersdorf Labor GmbH, Seibersdorf, Austria.,Department of Pharmacy, University of Tromsø-The Arctic University of Norway, Tromsø, Norway
| | - Günter Gmeiner
- Doping Control Laboratory, Seibersdorf Labor GmbH, Seibersdorf, Austria
| | - Peter Gärtner
- Institute of Applied Synthetic Chemistry, Technical University of Vienna, Austria
| | - Georg Stadler
- Institute of Applied Synthetic Chemistry, Technical University of Vienna, Austria
| | - Valentin Enev
- Institute of Applied Synthetic Chemistry, Technical University of Vienna, Austria
| | - Mario Thevis
- Institute of Biochemistry/Center for Preventive Doping Research, German Sport University Cologne, Cologne, Germany
| | - Wilhelm Schänzer
- Institute of Biochemistry/Center for Preventive Doping Research, German Sport University Cologne, Cologne, Germany
| | - Sven Guddat
- Institute of Biochemistry/Center for Preventive Doping Research, German Sport University Cologne, Cologne, Germany
| | - Guro Forsdahl
- Doping Control Laboratory, Seibersdorf Labor GmbH, Seibersdorf, Austria.,Department of Pharmacy, University of Tromsø-The Arctic University of Norway, Tromsø, Norway
| |
Collapse
|
5
|
Göschl L, Gmeiner G, Enev V, Kratena N, Gärtner P, Forsdahl G. Development and validation of a simple online‐SPE method coupled to high‐resolution mass spectrometry for the analysis of stanozolol‐N‐glucuronides in urine samples. Drug Test Anal 2020; 12:1031-1040. [DOI: 10.1002/dta.2805] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2019] [Revised: 04/01/2020] [Accepted: 04/11/2020] [Indexed: 01/24/2023]
Affiliation(s)
- Lorenz Göschl
- Doping Control Laboratory, Seibersdorf Labor GmbH Seibersdorf Austria
- Department of Pharmacy University of Tromsø – The Arctic University of Norway Tromsø Norway
| | - Günter Gmeiner
- Doping Control Laboratory, Seibersdorf Labor GmbH Seibersdorf Austria
| | - Valentin Enev
- Institute of Applied Synthetic Chemistry Technical University of Vienna Austria
| | - Nicolas Kratena
- Institute of Applied Synthetic Chemistry Technical University of Vienna Austria
| | - Peter Gärtner
- Institute of Applied Synthetic Chemistry Technical University of Vienna Austria
| | - Guro Forsdahl
- Doping Control Laboratory, Seibersdorf Labor GmbH Seibersdorf Austria
- Department of Pharmacy University of Tromsø – The Arctic University of Norway Tromsø Norway
| |
Collapse
|
6
|
Synthesis and characterization of stanozolol N-glucuronide metabolites. MONATSHEFTE FUR CHEMIE 2019. [DOI: 10.1007/s00706-019-02424-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
7
|
Souza Anselmo C, Sardela VF, Matias BF, Carvalho AR, Sousa VP, Pereira HMG, Aquino Neto FR. Is zebrafish
(
Danio rerio
)
a tool for human‐like metabolism study? Drug Test Anal 2017; 9:1685-1694. [DOI: 10.1002/dta.2318] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2017] [Revised: 09/26/2017] [Accepted: 09/27/2017] [Indexed: 02/06/2023]
Affiliation(s)
- Carina Souza Anselmo
- Federal University of Rio de Janeiro, Institute of Chemistry, LBCD – LADETEC Av. Horácio Macedo, 1281, bloco C ‐ Cidade Universitária, Rio de Janeiro ‐ RJ 21941‐598 Brazil
| | - Vinicius Figueiredo Sardela
- Federal University of Rio de Janeiro, Institute of Chemistry, LBCD – LADETEC Av. Horácio Macedo, 1281, bloco C ‐ Cidade Universitária, Rio de Janeiro ‐ RJ 21941‐598 Brazil
| | - Bernardo Fonseca Matias
- Federal University of Rio de Janeiro, Institute of Chemistry, LBCD – LADETEC Av. Horácio Macedo, 1281, bloco C ‐ Cidade Universitária, Rio de Janeiro ‐ RJ 21941‐598 Brazil
| | - Amanda Reis Carvalho
- Federal University of Rio de Janeiro, Institute of Chemistry, LBCD – LADETEC Av. Horácio Macedo, 1281, bloco C ‐ Cidade Universitária, Rio de Janeiro ‐ RJ 21941‐598 Brazil
| | - Valeria Pereira Sousa
- Federal University of Rio de Janeiro, Faculty of PharmacyDepartment of Drugs and Pharmaceutics Av. Carlos Chagas Filho, 373, bloco Bss, 36 ‐ Cidade Universitária, Rio de Janeiro ‐ RJ 21941‐170 Brazil
| | - Henrique Marcelo Gualberto Pereira
- Federal University of Rio de Janeiro, Institute of Chemistry, LBCD – LADETEC Av. Horácio Macedo, 1281, bloco C ‐ Cidade Universitária, Rio de Janeiro ‐ RJ 21941‐598 Brazil
| | - Francisco Radler Aquino Neto
- Federal University of Rio de Janeiro, Institute of Chemistry, LBCD – LADETEC Av. Horácio Macedo, 1281, bloco C ‐ Cidade Universitária, Rio de Janeiro ‐ RJ 21941‐598 Brazil
| |
Collapse
|
8
|
Wang Z, Zhou X, Liu X, Dong Y, Zhang J. A novel HPLC-MRM strategy to discover unknown and long-term metabolites of stanozolol for expanding analytical possibilities in doping-control. J Chromatogr B Analyt Technol Biomed Life Sci 2017; 1040:250-259. [DOI: 10.1016/j.jchromb.2016.11.006] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2016] [Revised: 10/24/2016] [Accepted: 11/05/2016] [Indexed: 12/18/2022]
|
9
|
Balcells G, Matabosch X, Ventura R. Detection of stanozolol O-
and N-
sulfate metabolites and their evaluation as additional markers in doping control. Drug Test Anal 2016; 9:1001-1010. [DOI: 10.1002/dta.2107] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2016] [Revised: 09/15/2016] [Accepted: 10/04/2016] [Indexed: 11/11/2022]
Affiliation(s)
- Georgina Balcells
- Bioanalysis Research Group, IMIM; Hospital del Mar Medical Research Institute; Doctor Aiguader 88 08003 Barcelona Spain
- Department of Experimental and Health Sciences; Universitat Pompeu Fabra; Doctor Aiguader 88 08003 Barcelona Spain
| | - Xavier Matabosch
- Bioanalysis Research Group, IMIM; Hospital del Mar Medical Research Institute; Doctor Aiguader 88 08003 Barcelona Spain
| | - Rosa Ventura
- Bioanalysis Research Group, IMIM; Hospital del Mar Medical Research Institute; Doctor Aiguader 88 08003 Barcelona Spain
- Department of Experimental and Health Sciences; Universitat Pompeu Fabra; Doctor Aiguader 88 08003 Barcelona Spain
| |
Collapse
|
10
|
Marcos J, Pozo OJ. Current LC-MS methods and procedures applied to the identification of new steroid metabolites. J Steroid Biochem Mol Biol 2016; 162:41-56. [PMID: 26709140 DOI: 10.1016/j.jsbmb.2015.12.012] [Citation(s) in RCA: 42] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/23/2015] [Revised: 11/25/2015] [Accepted: 12/11/2015] [Indexed: 12/31/2022]
Abstract
The study of the metabolism of steroids has a long history; from the first characterizations of the major metabolites of steroidal hormones in the pre-chromatographic era, to the latest discoveries of new forms of excretions. The introduction of mass spectrometers coupled to gas chromatography at the end of the 1960's represented a major breakthrough for the elucidation of new metabolites. In the last two decades, this technique is being complemented by the use of liquid chromatography-mass spectrometry (LC-MS). In addition of becoming fundamental in clinical steroid determinations due to its excellent specificity, throughput and sensitivity, LC-MS has emerged as an exceptional tool for the discovery of new steroid metabolites. The aim of the present review is to provide an overview of the current LC-MS procedures used in the quest of novel metabolic products of steroidal hormones and exogenous steroids. Several aspects regarding LC separations are first outlined, followed by a description of the key processes that take place in the mass spectrometric analysis, i.e. the ionization of the steroids in the source and the fragmentation of the selected precursor ions in the collision cell. The different analyzers and approaches employed together with representative examples of each of them are described. Special emphasis is placed on triple quadrupole analyzers (LC-MS/MS), since they are the most commonly employed. Examples on the use of precursor ion scan, neutral loss scan and theoretical selected reaction monitoring strategies are also explained.
Collapse
Affiliation(s)
- Josep Marcos
- Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Doctor Aiguader 88, 08003 Barcelona, Spain; Toxicology Department, Labco Diagnostics, Verge de Guadalupe 18, 08950 Esplugues de Llobregat, Spain
| | - Oscar J Pozo
- Bioanalysis Research Group, IMIM, Hospital del Mar, Doctor Aiguader 88, 08003 Barcelona, Spain.
| |
Collapse
|
11
|
Polet M, Van Gansbeke W, Van Eenoo P, Deventer K. Efficient approach for the detection and identification of new androgenic metabolites by applying SRM GC-CI-MS/MS: a methandienone case study. JOURNAL OF MASS SPECTROMETRY : JMS 2016; 51:524-534. [PMID: 27434811 DOI: 10.1002/jms.3781] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/11/2016] [Revised: 04/04/2016] [Accepted: 04/26/2016] [Indexed: 06/06/2023]
Abstract
Identification of anabolic androgenic steroids (AAS) is a vital issue in doping control and toxicology, and searching for metabolites with longer detection times remains an important task. Recently, a gas chromatography chemical ionization triple quadrupole mass spectrometry (GC-CI-MS/MS) method was introduced, and CI, in comparison with electron ionization (EI), proved to be capable of increasing the sensitivity significantly. In addition, correlations between AAS structure and fragmentation behavior could be revealed. This enables the search for previously unknown but expected metabolites by selection of their predicted transitions. The combination of both factors allows the setup of an efficient approach to search for new metabolites. The approach uses selected reaction monitoring which is inherently more sensitive than full scan or precursor ion scan. Additionally, structural information obtained from the structure specific CI fragmentation pattern facilitates metabolite identification. The procedure was demonstrated by a methandienone case study. Its metabolites have been studied extensively in the past, and this allowed an adequate evaluation of the efficiency of the approach. Thirty three metabolites were detected, including all relevant previously discovered metabolites. In our study, the previously reported long-term metabolite (18-nor-17β-hydroxymethyl,17α-methyl-androst-1,4,13-trien-3-one) could be detected up to 26 days by using GC-CI-MS/MS. The study proves the validity of the approach to search for metabolites of new synthetic AAS and new long-term metabolites of less studied AAS and illustrates the increase in sensitivity by using CI. Copyright © 2016 John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- Michael Polet
- Ghent University, Department of Clinical Chemistry, Microbiology and Immunology, Doping Control Laboratory, Technologiepark 30 B, B-9052, Zwijnaarde, Belgium
| | - Wim Van Gansbeke
- Ghent University, Department of Clinical Chemistry, Microbiology and Immunology, Doping Control Laboratory, Technologiepark 30 B, B-9052, Zwijnaarde, Belgium
| | - Peter Van Eenoo
- Ghent University, Department of Clinical Chemistry, Microbiology and Immunology, Doping Control Laboratory, Technologiepark 30 B, B-9052, Zwijnaarde, Belgium
| | - Koen Deventer
- Ghent University, Department of Clinical Chemistry, Microbiology and Immunology, Doping Control Laboratory, Technologiepark 30 B, B-9052, Zwijnaarde, Belgium
| |
Collapse
|
12
|
Detection and characterization of clostebol sulfate metabolites in Caucasian population. J Chromatogr B Analyt Technol Biomed Life Sci 2016; 1022:54-63. [DOI: 10.1016/j.jchromb.2016.03.028] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2016] [Revised: 03/09/2016] [Accepted: 03/19/2016] [Indexed: 02/02/2023]
|
13
|
Geldof L, Lootens L, Decroix L, Botrè F, Meuleman P, Leroux-Roels G, Deventer K, Van Eenoo P. Metabolic studies of prostanozol with the uPA-SCID chimeric mouse model and human liver microsomes. Steroids 2016; 107:139-48. [PMID: 26774429 DOI: 10.1016/j.steroids.2016.01.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/31/2015] [Revised: 12/18/2015] [Accepted: 01/07/2016] [Indexed: 11/22/2022]
Abstract
Anabolic androgenic steroids are prohibited by the World Anti-Doping Agency because of their adverse health and performance enhancing effects. Effective control of their misuse by detection in urine requires knowledge about their metabolism. In case of designer steroids, ethical objections limit the use of human volunteers to perform excretion studies. Therefore the suitability of alternative models needs to be investigated. In this study pooled human liver microsomes (HLM) and an uPA(+/+)-SCID chimeric mouse model were used to examine the metabolism of the designer steroid prostanozol as a reference standard. Metabolites were detected by GC-MS (full scan) and LC-MS/MS (precursor ion scan). In total twenty-four prostanozol metabolites were detected with the in vitro and in vivo metabolism studies, which could be grouped into two broad classes, those with a 17-hydroxy- and those with a 17-keto-substituent. Major first phase metabolic sites were tentatively identified as C-3'; C-4 and C-16. Moreover, 3'- and 16β-hydroxy-17-ketoprostanozol could be unequivocally identified, since authentic reference material was available, in both models. Comparison with published data from humans showed a good correlation, except for phase II metabolism. As metabolites were in contrast to the human studies predominantly present in the free fraction. Two types of metabolites ((di)hydroxylated prostanozol metabolites) that have not been described before could be confirmed in a real positive doping control sample. Hence, the results provide further evidence for the applicability of chimeric mice and HLM to perform metabolism studies of designer steroids.
Collapse
Affiliation(s)
- Lore Geldof
- Doping Control Laboratory (DoCoLab), Technologiepark 30 B, B-9052 Zwijnaarde, Belgium.
| | - Leen Lootens
- Doping Control Laboratory (DoCoLab), Technologiepark 30 B, B-9052 Zwijnaarde, Belgium
| | - Lieselot Decroix
- Doping Control Laboratory (DoCoLab), Technologiepark 30 B, B-9052 Zwijnaarde, Belgium
| | - Francesco Botrè
- Antidoping Lab, Federazione Medico Sportiva Italiana (FMSI), Largo Giulio Onesti 1, I-00197 Rome, Italy
| | - Philip Meuleman
- Center for Vaccinology (CEVAC), Ghent University and Hospital, De Pintelaan 185, B-9000 Ghent, Belgium
| | - Geert Leroux-Roels
- Center for Vaccinology (CEVAC), Ghent University and Hospital, De Pintelaan 185, B-9000 Ghent, Belgium
| | - Koen Deventer
- Doping Control Laboratory (DoCoLab), Technologiepark 30 B, B-9052 Zwijnaarde, Belgium
| | - Peter Van Eenoo
- Doping Control Laboratory (DoCoLab), Technologiepark 30 B, B-9052 Zwijnaarde, Belgium
| |
Collapse
|
14
|
Potential of atmospheric pressure chemical ionization source in gas chromatography tandem mass spectrometry for the screening of urinary exogenous androgenic anabolic steroids. Anal Chim Acta 2016; 906:128-138. [DOI: 10.1016/j.aca.2015.11.041] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2015] [Revised: 11/11/2015] [Accepted: 11/26/2015] [Indexed: 01/28/2023]
|
15
|
|
16
|
Abstract
Most of what we know about a drug prior to human clinical studies is derived from animal testing. Because animals and humans have substantial differences in their physiology and in their drug metabolism pathways, we do not know very much about the pharmacokinetic and pharmacodynamic behavior of a drug in humans until after it is administered to many people. Hence, drug-induced liver injury has become a significant public health problem, and we have a very inefficient drug development process with a high failure rate. Because the human liver is at the heart of these problems, chimeric mice with humanized livers could be used to address these issues. We examine recent evidence indicating that drug testing in chimeric mice could provide better information about a drug's metabolism, disposition, and toxicity (i.e., its "behavior") in humans and could aid in developing personalized medicine strategies, which would improve drug efficacy and safety.
Collapse
Affiliation(s)
- Dan Xu
- Department of Anesthesia, Stanford University School of Medicine, Stanford, California 94305;
| | - Gary Peltz
- Department of Anesthesia, Stanford University School of Medicine, Stanford, California 94305;
| |
Collapse
|
17
|
Ruokolainen M, Valkonen M, Sikanen T, Kotiaho T, Kostiainen R. Imitation of phase I oxidative metabolism of anabolic steroids by titanium dioxide photocatalysis. Eur J Pharm Sci 2014; 65:45-55. [DOI: 10.1016/j.ejps.2014.08.009] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2014] [Revised: 08/15/2014] [Accepted: 08/19/2014] [Indexed: 01/13/2023]
|
18
|
Kotronoulas A, Fabregat A, Alfonso I, Parella T, Segura J, Ventura R, Joglar J, Pozo OJ. Synthesis and characterization of 6β-hydroxyandrosterone and 6β-hydroxyetiocholanolone conjugated with glucuronic acid. Drug Test Anal 2014; 7:247-52. [DOI: 10.1002/dta.1738] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2014] [Revised: 09/25/2014] [Accepted: 09/29/2014] [Indexed: 11/09/2022]
Affiliation(s)
- Aristotelis Kotronoulas
- Bioanalysis Research Group; IMIM, Hospital del Mar; Doctor Aiguader 88 08003 Barcelona Spain
- Department of Biological Chemistry and Molecular Modelling; Institute of Advanced Chemistry of Catalonia, Spanish Council for Scientific Research (IQAC-CSIC); Jordi Girona 18-26 08034 Barcelona Spain
| | - Andreu Fabregat
- Bioanalysis Research Group; IMIM, Hospital del Mar; Doctor Aiguader 88 08003 Barcelona Spain
| | - Ignacio Alfonso
- Department of Biological Chemistry and Molecular Modelling; Institute of Advanced Chemistry of Catalonia, Spanish Council for Scientific Research (IQAC-CSIC); Jordi Girona 18-26 08034 Barcelona Spain
| | - Teodor Parella
- Dept Química and Servei de Ressonància Magnètica Nuclear; Universitat Autònoma de Barcelona; Bellaterra Spain
| | - Jordi Segura
- Bioanalysis Research Group; IMIM, Hospital del Mar; Doctor Aiguader 88 08003 Barcelona Spain
- Department of Experimental and Health Sciences; Universitat Pompeu Fabra; Doctor Aiguader 88 08003 Barcelona Spain
| | - Rosa Ventura
- Bioanalysis Research Group; IMIM, Hospital del Mar; Doctor Aiguader 88 08003 Barcelona Spain
- Department of Experimental and Health Sciences; Universitat Pompeu Fabra; Doctor Aiguader 88 08003 Barcelona Spain
| | - Jesús Joglar
- Department of Biological Chemistry and Molecular Modelling; Institute of Advanced Chemistry of Catalonia, Spanish Council for Scientific Research (IQAC-CSIC); Jordi Girona 18-26 08034 Barcelona Spain
| | - Oscar J. Pozo
- Bioanalysis Research Group; IMIM, Hospital del Mar; Doctor Aiguader 88 08003 Barcelona Spain
| |
Collapse
|
19
|
Mazzarino M, de la Torre X, Fiacco I, Botrè F. Drug-drug interaction and doping, part 2: Anin vitrostudy on the effect of non-prohibited drugs on the phase I metabolic profile of stanozolol. Drug Test Anal 2014; 6:969-77. [DOI: 10.1002/dta.1608] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2013] [Revised: 11/08/2013] [Accepted: 12/22/2013] [Indexed: 12/17/2022]
Affiliation(s)
- Monica Mazzarino
- Laboratorio Antidoping; Federazione Medico Sportiva Italiana; Largo Giulio Onesti, 1 00197 Rome Italy
| | - Xavier de la Torre
- Laboratorio Antidoping; Federazione Medico Sportiva Italiana; Largo Giulio Onesti, 1 00197 Rome Italy
| | - Ilaria Fiacco
- Laboratorio Antidoping; Federazione Medico Sportiva Italiana; Largo Giulio Onesti, 1 00197 Rome Italy
| | - Francesco Botrè
- Laboratorio Antidoping; Federazione Medico Sportiva Italiana; Largo Giulio Onesti, 1 00197 Rome Italy
- Dipartimento di Medicina Sperimentale; ‘Sapienza’ Università di Roma; Viale Regina Elena 324 00161 Rome Italy
| |
Collapse
|
20
|
Confirmatory analysis of stanozolol metabolites in bovine, pig and sheep urines using an optimized clean-up and liquid chromatography–tandem mass spectrometry. J Pharm Biomed Anal 2014; 88:45-52. [DOI: 10.1016/j.jpba.2013.08.019] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2013] [Revised: 08/16/2013] [Accepted: 08/17/2013] [Indexed: 11/22/2022]
|
21
|
Gomez C, Fabregat A, Pozo ÓJ, Marcos J, Segura J, Ventura R. Analytical strategies based on mass spectrometric techniques for the study of steroid metabolism. Trends Analyt Chem 2014. [DOI: 10.1016/j.trac.2013.08.010] [Citation(s) in RCA: 57] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
|
22
|
Foster JR, Lund G, Sapelnikova S, Tyrrell DL, Kneteman NM. Chimeric rodents with humanized liver: bridging the preclinical/clinical trial gap in ADME/toxicity studies. Xenobiotica 2013; 44:109-22. [DOI: 10.3109/00498254.2013.867553] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
23
|
Current status and bioanalytical challenges in the detection of unknown anabolic androgenic steroids in doping control analysis. Bioanalysis 2013; 5:2661-77. [DOI: 10.4155/bio.13.242] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
Androgenic anabolic steroids (AAS) are prohibited in sports due to their anabolic effects. Doping control laboratories usually face the screening of AAS misuse by target methods based on MS detection. Although these methods allow for the sensitive and specific detection of targeted compounds and metabolites, the rest remain undetectable. This fact opens a door for cheaters, since different AAS can be synthesized in order to evade doping control tests. This situation was evidenced in 2003 with the discovery of the designer steroid tetrahydrogestrinone. One decade after this discovery, the detection of unknown AAS still remains one of the main analytical challenges in the doping control field. In this manuscript, the current situation in the detection of unknown AAS is reviewed. Although important steps have been made in order to minimize this analytical problem and different analytical strategies have been proposed, there are still some drawbacks related to each approach.
Collapse
|
24
|
Schänzer W, Guddat S, Thomas A, Opfermann G, Geyer H, Thevis M. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing. Drug Test Anal 2013; 5:810-8. [DOI: 10.1002/dta.1516] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2013] [Revised: 06/26/2013] [Accepted: 06/26/2013] [Indexed: 11/08/2022]
Affiliation(s)
- Wilhelm Schänzer
- Institute of Biochemistry - Center for Preventive Doping Research; German Sport University Cologne; Am Sportpark Müngersdorf 6 50933 Cologne Germany
| | - Sven Guddat
- Institute of Biochemistry - Center for Preventive Doping Research; German Sport University Cologne; Am Sportpark Müngersdorf 6 50933 Cologne Germany
| | - Andreas Thomas
- Institute of Biochemistry - Center for Preventive Doping Research; German Sport University Cologne; Am Sportpark Müngersdorf 6 50933 Cologne Germany
| | - Georg Opfermann
- Institute of Biochemistry - Center for Preventive Doping Research; German Sport University Cologne; Am Sportpark Müngersdorf 6 50933 Cologne Germany
| | - Hans Geyer
- Institute of Biochemistry - Center for Preventive Doping Research; German Sport University Cologne; Am Sportpark Müngersdorf 6 50933 Cologne Germany
| | - Mario Thevis
- Institute of Biochemistry - Center for Preventive Doping Research; German Sport University Cologne; Am Sportpark Müngersdorf 6 50933 Cologne Germany
- European Monitoring Center for Emerging Doping Agents; Cologne/Bonn Germany
| |
Collapse
|
25
|
Peltz G. Can 'humanized' mice improve drug development in the 21st century? Trends Pharmacol Sci 2013; 34:255-60. [PMID: 23602782 PMCID: PMC3682766 DOI: 10.1016/j.tips.2013.03.005] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2013] [Revised: 03/15/2013] [Accepted: 03/15/2013] [Indexed: 02/08/2023]
Abstract
Chimeric mice, which have human hepatocytes engrafted in their liver, have been used to study human drug metabolism and pharmacodynamic responses for nearly 20 years. However, there are very few examples where their use has prospectively impacted the development of a candidate medication. Here, three different chimeric mouse models and their utility for pharmacology studies are evaluated. Several recent studies indicate that using these chimeric mouse models could help to overcome traditional (predicting human-specific metabolites and toxicities) and 21st century problems (strategies for personalized medicine and selection of optimal combination therapies) in drug development. These examples suggest that there are many opportunities in which the use of chimeric mice could significantly improve the quality of preclinical drug assessment.
Collapse
Affiliation(s)
- Gary Peltz
- Department of Anesthesia, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA.
| |
Collapse
|
26
|
Sensitive detection of 3′-hydroxy-stanozolol glucuronide by liquid chromatography–tandem mass spectrometry. J Chromatogr A 2013; 1292:195-200. [DOI: 10.1016/j.chroma.2013.01.001] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2012] [Revised: 11/22/2012] [Accepted: 01/02/2013] [Indexed: 11/18/2022]
|
27
|
Gosetti F, Mazzucco E, Gennaro MC, Marengo E. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review. J Chromatogr B Analyt Technol Biomed Life Sci 2013; 927:22-36. [DOI: 10.1016/j.jchromb.2012.12.003] [Citation(s) in RCA: 92] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2012] [Revised: 12/03/2012] [Accepted: 12/04/2012] [Indexed: 01/15/2023]
|
28
|
Abstract
Though we may still sing today, as did Pindar in his eighth Olympian Victory Ode, "… of no contest greater than Olympia, Mother of Games, gold-wreathed Olympia…", we must sadly admit that today, besides blatant over-commercialization, there is no more ominous threat to the Olympic games than doping. Drug-use methods are steadily becoming more sophisticated and ever harder to detect, increasingly demanding the use of complex analytical procedures of biotechnology and molecular medicine. Special emphasis is thus given to anabolic androgenic steroids, recombinant growth hormone and erythropoietin as well as to gene doping, the newly developed mode of hormones abuse which, for its detection, necessitates high-tech methodology but also multidisciplinary individual measures incorporating educational and psychological methods. In this Olympic year, the present review offers an update on the current technologically advanced endocrine methods of doping while outlining the latest procedures applied-including both the successes and pitfalls of proteomics and metabolomics-to detect doping while contributing to combating this scourge.
Collapse
Affiliation(s)
- Leonidas H Duntas
- Endocrine Unit, Evgenidion Hospital, University of Athens, 20 Papadiamantopoulou Street, 11528, Athens, Greece.
| | | |
Collapse
|
29
|
Cavalcanti GDA, Leal FD, Garrido BC, Padilha MC, de Aquino Neto FR. Detection of designer steroid methylstenbolone in "nutritional supplement" using gas chromatography and tandem mass spectrometry: elucidation of its urinary metabolites. Steroids 2013. [PMID: 23200734 DOI: 10.1016/j.steroids.2012.11.009] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The use of "nutritional supplements" containing unapproved substances has become a regular practice in amateur and professional athletes. This represents a dangerous habit for their health once no data about toxicological or pharmacological effects of these supplements are available. Most of them are freely commercialized online and any person can buy them without medical surveillance. Usually, the steroids intentionally added to the "nutritional supplements" are testosterone analogues with some structural modifications. In this study, the analyzed product was bought online and a new anabolic steroid known as methylstenbolone (2,17α-dimethyl-17β-hydroxy-5α-androst-1-en-3-one) was detected, as described on label. Generally, anabolic steroids are extensively metabolized, thus in-depth knowledge of their metabolism is mandatory for doping control purposes. For this reason, a human excretion study was carried out with four volunteers after a single oral dose to determine the urinary metabolites of the steroid. Urine samples were submitted to enzymatic hydrolysis of glucuconjugated metabolites followed by liquid-liquid extraction and analysis of the trimethylsilyl derivatives by gas chromatography coupled to tandem mass spectrometry. Mass spectrometric data allowed the proposal of two plausible metabolites: 2,17α-dimethyl-16ξ,17β-dihydroxy-5α-androst-1-en-3-one (S1), 2,17α-dimethyl-3α,16ξ,17β-trihydroxy-5α-androst-1-ene (S2). Their electron impact mass spectra are compatible with 16-hydroxylated steroids O-TMS derivatives presenting diagnostic ions such as m/z 231 and m/z 218. These metabolites were detectable after one week post administration while unchanged methylstenbolone was only detectable in a brief period of 45 h.
Collapse
|
30
|
Gómez C, Pozo OJ, Marcos J, Segura J, Ventura R. Alternative long-term markers for the detection of methyltestosterone misuse. Steroids 2013; 78:44-52. [PMID: 23127819 DOI: 10.1016/j.steroids.2012.10.008] [Citation(s) in RCA: 59] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/21/2012] [Revised: 09/28/2012] [Accepted: 10/10/2012] [Indexed: 10/27/2022]
Abstract
Methyltestosterone (MT) is one of the most frequently detected anabolic androgenic steroids in doping control analysis. MT misuse is commonly detected by the identification of its two main metabolites excreted as glucuronide conjugates, 17α-methyl-5α-androstan-3α,17β-diol and 17α-methyl-5β-androstan-3α,17β-diol. The detection of these metabolites is normally performed by gas chromatography-mass spectrometry, after previous hydrolysis with β-glucuronidase enzymes, extraction and derivatization steps. The aim of the present work was to study the sulphate fraction of MT and to evaluate their potential to improve the detection of the misuse of the drug in sports. MT was administered to healthy volunteers and urine samples were collected up to 30days after administration. After an extraction with ethyl acetate, urine extracts were analysed by liquid chromatography tandem mass spectrometry using electrospray ionisation in negative mode by monitoring the transition m/z 385 to m/z 97. Three diol sulphate metabolites (S1, S2 and S3) were detected. Potential structures for these metabolites were proposed after solvolysis and mass spectrometric experiments: S1, 17α-methyl-5β-androstan-3α,17β-diol 3α-sulphate; S2, 17β-methyl-5α-androstan-3α,17α-diol 3α-sulphate; and S3, 17β-methyl-5β-androstan-3α,17α-diol 3α-sulphate. Synthesis of reference compounds will be required in order to confirm the structures. The retrospectivity of these sulphate metabolites in the detection of MT misuse was compared with the obtained with previously described metabolites. Metabolite S2 was detected up to 21days after MT administration, improving between 2 and 3 times the retrospectivity of the detection compared to the last long-term metabolite of MT previously described, 17α-hydroxy-17β-methylandrostan-4,6-dien-3-one.
Collapse
Affiliation(s)
- C Gómez
- Bioanalysis Research Group, IMIM-Hospital del Mar, Barcelona, Spain
| | | | | | | | | |
Collapse
|
31
|
Deshmukh NI, Zachar G, Petróczi A, Székely AD, Barker J, Naughton DP. Determination of stanozolol and 3'-hydroxystanozolol in rat hair, urine and serum using liquid chromatography tandem mass spectrometry. Chem Cent J 2012; 6:162. [PMID: 23259549 PMCID: PMC3542005 DOI: 10.1186/1752-153x-6-162] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2012] [Accepted: 12/18/2012] [Indexed: 01/25/2023] Open
Abstract
Background Anabolic androgenic steroids, such as stanozolol, are typically misused by athletes during preparation for competition. Out-of-competition testing presents a unique challenge in the current anti-doping detection system owing to logistic reasons. Analysing hair for the presence of a prohibited drug offers a feasible solution for covering the wider window in out-of-competition testing. To assist in vivo studies aiming to establish a relationship between drug levels detected in hair, urine and blood, sensitive methods for the determination of stanozolol and its major metabolite 3′-hydroxystanozolol were developed in pigmented hair, urine and serum, using brown Norway rats as a model system and liquid chromatography tandem mass spectrometry (LC-MS/MS). Results For method development, spiked drug free rat hair, blood and urine samples were used. The newly developed method was then applied to hair, urine and serum samples from five brown Norway rats after treatment (intraperitoneal) with stanozolol for six consecutive days at 5.0 mg/kg/day. The assay for each matrix was linear within the quantification range with determination coefficient (r2) values above 0.995. The respective assay was capable of detecting 0.125 pg/mg stanozolol and 0.25 pg/mg 3′-hydroxystanozolol with 50 mg hair; 0.063 ng/mL stanozolol and 0.125 ng/mL 3′-hydroxystanozolol with 100 μL of urine or serum. The accuracy, precision and extraction recoveries of the assays were satisfactory for the detection of both compounds in all three matrices. The average concentrations of stanozolol and 3′-hydroxystanozolol, were as follows: hair = 70.18 ± 22.32 pg/mg and 13.01 ± 3.43 pg/mg; urine = 4.34 ± 6.54 ng/mL and 9.39 ± 7.42 ng/mL; serum = 7.75 ± 3.58 ng/mL and 7.16 ± 1.97 ng/mL, respectively. Conclusions The developed methods are sensitive, specific and reproducible for the determination of stanozolol and 3′-hydroxystanozolol in rat hair, urine and serum. These methods can be used for in vivo studies further investigating stanozolol metabolism, but also could be extended for doping testing. Owing to the complementary nature of these tests, with urine and serum giving information on recent drug use and hair providing retrospective information on habitual use, it is suggested that blood or urine tests could accompany hair analysis and thus avoid false doping results.
Collapse
Affiliation(s)
- Nawed Ik Deshmukh
- School of Pharmacy and Chemistry, Kingston University, Penrhyn Road, Kingston upon Thames, Surrey, KT1 2EE, UK.
| | | | | | | | | | | |
Collapse
|
32
|
Nishimura T, Nishimura T, Hu Y, Wu M, Pham E, Suemizu H, Elazar M, Liu M, Idilman R, Yurdaydin C, Angus P, Stedman C, Murphy B, Glenn J, Nakamura M, Nomura T, Chen Y, Zheng M, Fitch WL, Peltz G. Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interaction. J Pharmacol Exp Ther 2012; 344:388-96. [PMID: 23143674 DOI: 10.1124/jpet.112.198697] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
Interspecies differences in drug metabolism have made it difficult to use preclinical animal testing data to predict the drug metabolites or potential drug-drug interactions (DDIs) that will occur in humans. Although chimeric mice with humanized livers can produce known human metabolites for test substrates, we do not know whether chimeric mice can be used to prospectively predict human drug metabolism or a possible DDI. Therefore, we investigated whether they could provide a more predictive assessment for clemizole, a drug in clinical development for the treatment of hepatitis C virus (HCV) infection. Our results demonstrate, for the first time, that analyses performed in chimeric mice can correctly identify the predominant human drug metabolite before human testing. The differences in the rodent and human pathways for clemizole metabolism were of importance, because the predominant human metabolite was found to have synergistic anti-HCV activity. Moreover, studies in chimeric mice also correctly predicted that a DDI would occur in humans when clemizole was coadministered with a CYP3A4 inhibitor. These results demonstrate that using chimeric mice can improve the quality of preclinical drug assessment.
Collapse
Affiliation(s)
- Toshihiko Nishimura
- Department of Anesthesia, Stanford University School of Medicine, Stanford, California, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Gómez C, Pozo OJ, Geyer H, Marcos J, Thevis M, Schänzer W, Segura J, Ventura R. New potential markers for the detection of boldenone misuse. J Steroid Biochem Mol Biol 2012; 132:239-46. [PMID: 22664392 DOI: 10.1016/j.jsbmb.2012.05.010] [Citation(s) in RCA: 50] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/28/2012] [Revised: 05/17/2012] [Accepted: 05/18/2012] [Indexed: 10/28/2022]
Abstract
Boldenone is one of the most frequently detected anabolic androgenic steroids in doping control analysis. Boldenone misuse is commonly detected by the identification of the active drug and its main metabolite, 5β-androst-1-en-17β-ol-3-one (BM1), by gas chromatography-mass spectrometry (GC-MS), after previous hydrolysis with β-glucuronidase enzymes, extraction and derivatization steps. However, some cases of endogenous boldenone and BM1 have been reported. Nowadays, when these compounds are detected in urine at low concentrations, isotope ratio mass spectrometry (IRMS) analysis is needed to confirm their exogenous origin. The aim of the present study was to identify boldenone metabolites conjugated with sulphate and to evaluate their potential to improve the detection of boldenone misuse in sports. Boldenone was administered to a healthy volunteer and urine samples were collected up to 56h after administration. After a liquid-liquid extraction with ethyl acetate, urine extracts were analysed by liquid chromatography tandem mass spectrometry (LC-MS/MS) using electrospray ionisation in negative mode by monitoring the transition of m/z 365-350, specific for boldenone sulphate. Boldenone sulphate was identified in the excretion study urine samples and, moreover, another peak with the same transition was observed. Based on the MS/MS behaviour the metabolite was identified as epiboldenone sulphate. The identity was confirmed by isolation of the LC peak, solvolysis and comparison of the retention time and MS/MS spectra with an epiboldenone standard. These sulphated metabolites have not been previously reported in humans and although they account for less than 1% of the administered dose, they were still present in urine when the concentrations of the major metabolites, boldenone and BM1, were at the level of endogenous origin. The sulphated metabolites were also detected in 10 urine samples tested positive to boldenone and BM1 by GC-MS. In order to verify the usefulness of these new metabolites to discriminate between endogenous and exogenous origin of boldenone, four samples containing endogenous boldenone and BM1, confirmed by IRMS, were analysed. In 3 of the 4 samples, neither boldenone sulphate nor epiboldenone sulphate were detected, confirming that these metabolites were mainly detected after exogenous administration of boldenone. In contrast, boldenone sulphate and, in some cases, epiboldenone sulphate were present in samples with low concentrations of exogenous boldenone and BM1. Thus, boldenone and epiboldenone sulphates are additional markers for the exogenous origin of boldenone and they can be used to reduce the number of samples to be analysed by IRMS. In samples with boldenone and BM1 at the concentrations suspicion for endogenous origin, only if boldenone and epiboldenone sulphates are present, further analysis by IRMS will be needed to confirm exogenous origin.
Collapse
Affiliation(s)
- C Gómez
- Bioanalysis and Analytical Services Research Group, Neurosciences Program, IMIM, Institut de Recerca Hospital del Mar, Barcelona, Spain
| | | | | | | | | | | | | | | |
Collapse
|
34
|
Pozo OJ, Gómez C, Marcos J, Segura J, Ventura R. Detection and characterization of urinary metabolites of boldione by LC-MS/MS. Part II: Conjugates with cysteine andN-acetylcysteine. Drug Test Anal 2012; 4:786-97. [DOI: 10.1002/dta.1431] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2012] [Revised: 09/14/2012] [Accepted: 09/25/2012] [Indexed: 11/12/2022]
Affiliation(s)
- Oscar J. Pozo
- Bioanalysis Research Group, IMIM, Hospital del Mar; Doctor Aiguader 88; 08003; Barcelona; Spain
| | | | | | | | | |
Collapse
|
35
|
Sensitive and robust method for anabolic agents in human urine by gas chromatography–triple quadrupole mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2012; 897:85-9. [DOI: 10.1016/j.jchromb.2012.03.037] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2012] [Revised: 03/19/2012] [Accepted: 03/25/2012] [Indexed: 11/17/2022]
|
36
|
Pozo OJ, Marcos J, Matabosch X, Ventura R, Segura J. Using complementary mass spectrometric approaches for the determination of methylprednisolone metabolites in human urine. RAPID COMMUNICATIONS IN MASS SPECTROMETRY : RCM 2012; 26:541-553. [PMID: 22302494 DOI: 10.1002/rcm.6129] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
RATIONALE The metabolism of methylprednisolone is revisited in order to find new metabolites that could be important for distinguishing between different routes of administration. Recently developed liquid chromatography/tandem mass spectrometry (LC/MS/MS) strategies for the detection of corticosteroid metabolites have been applied to the study of methylprednisolone metabolism. METHODS The structures of these metabolites were studied using two complementary mass spectrometric techniques: LC/MS/MS in product ion scan mode with electrospray ionization and gas chromatography/mass spectrometry (GC/MS) in full scan mode with electron ionization. Metabolites were also isolated by semipreparative liquid chromatography fractionation. Each fraction was divided into two aliquots; one was studied by LC/MS/MS and the other by GC/MS after methoxyamine-trimethylsilyl derivatization. RESULTS The combination of all the structural information allowed us to propose a comprehensive picture of methylprednisolone metabolism in humans. Overall, 15 metabolites including five previously unreported compounds have been detected. Specifically, 16β,17α,21-trihydroxy-6α-methylpregna-1,4-diene-3,11,20-trione, 17α,20β,21-trihydroxy-6α-methylpregna-1,4-diene-3, 11-dione, 11β,17α,21-trihydroxy-6α-hydroxymethylpregna-1,4-diene-3,20-dione, 11β,17α,20ξ,21-tetrahydroxy-6α-hydroxymethylpregna-1,4-diene-3-one, and 17α,21-dihydroxy-6α-hydroxymethylpregna-1,4-diene-3,11,20-trione are proposed as feasible structures for the novel metabolites. In addition to the expected biotransformations: reduction of the C20 carbonyl, oxidation of the C11 hydroxy group, and further 6β-hydroxylation, we propose that hydroxylation of the 6α-methyl group can also take place. CONCLUSIONS New metabolites have been identified in urine samples collected after oral administration of 40 mg of methylprednisolone. All identified metabolites were found in all samples collected up to 36 h after oral administration. However, after topical administration of 5 g of methylprednisolone aceponate, neither the parent compound nor any of the metabolites were detected.
Collapse
Affiliation(s)
- Oscar J Pozo
- Bioanalysis Research Group, IMIM, Institut de Recerca Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain
| | | | | | | | | |
Collapse
|
37
|
Recent developments in MS for small molecules: application to human doping control analysis. Bioanalysis 2012; 4:197-212. [DOI: 10.4155/bio.11.305] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023] Open
Abstract
Recent developments in MS for the detection of small molecules in the context of doping control analysis are reviewed. Doping control analysis is evolving together with MS, which is the technique of choice in order to accomplish the analytical requirements in this field. Since these analytical requirements for the detection of a doping agent depend on the substance, in the first section we review the different scenarios. The commonly established approaches, together with their achievements and drawbacks are described. New developments in hyphenated MS techniques (both GC–MS/MS and LC–MS/MS) concerning interfaces and analyzers are mentioned. The use (or potential use) of these developments in order to minimize the limitations of the commonly established approaches in the doping control field is discussed. Finally, a brief discussion about trends and remaining limitations is presented.
Collapse
|
38
|
Current status of hyphenated mass spectrometry in studies of the metabolism of drugs of abuse, including doping agents. Anal Bioanal Chem 2011; 402:195-208. [DOI: 10.1007/s00216-011-5331-6] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2011] [Revised: 08/05/2011] [Accepted: 08/06/2011] [Indexed: 01/30/2023]
|
39
|
Mass spectrometric characterization of urinary toremifene metabolites for doping control analyses. J Chromatogr A 2011; 1218:4727-37. [DOI: 10.1016/j.chroma.2011.05.073] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2010] [Revised: 03/18/2011] [Accepted: 05/18/2011] [Indexed: 11/22/2022]
|
40
|
Thevis M, Thomas A, Schänzer W. Current role of LC-MS(/MS) in doping control. Anal Bioanal Chem 2011; 401:405-20. [DOI: 10.1007/s00216-011-4859-9] [Citation(s) in RCA: 71] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2011] [Revised: 02/24/2011] [Accepted: 02/26/2011] [Indexed: 11/30/2022]
|
41
|
Cole RB, Rannulu NS. Regioselective anion attachment leading to regiospecific decompositions of bifunctional steroids in negative ion electrospray tandem mass spectrometry. RAPID COMMUNICATIONS IN MASS SPECTROMETRY : RCM 2011; 25:558-562. [PMID: 21259365 DOI: 10.1002/rcm.4884] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
|
42
|
Thevis M, Kuuranne T, Geyer H, Schänzer W. Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test Anal 2011; 3:1-14. [DOI: 10.1002/dta.245] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2010] [Accepted: 11/19/2010] [Indexed: 12/13/2022]
|
43
|
Hasegawa M, Kawai K, Mitsui T, Taniguchi K, Monnai M, Wakui M, Ito M, Suematsu M, Peltz G, Nakamura M, Suemizu H. The reconstituted 'humanized liver' in TK-NOG mice is mature and functional. Biochem Biophys Res Commun 2011; 405:405-10. [PMID: 21238430 DOI: 10.1016/j.bbrc.2011.01.042] [Citation(s) in RCA: 244] [Impact Index Per Article: 18.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2010] [Accepted: 01/11/2011] [Indexed: 12/25/2022]
Abstract
To overcome the limitations of existing models, we developed a novel experimental in vivo platform for replacing mouse liver with functioning human liver tissue. To do this, a herpes simplex virus type 1 thymidine kinase (HSVtk) transgene was expressed within the liver of highly immunodeficient NOG mice (TK-NOG). Mouse liver cells expressing this transgene were ablated after a brief exposure to a non-toxic dose of ganciclovir (GCV), and transplanted human liver cells are stably maintained within the liver (humanized TK-NOG) without exogenous drug. The reconstituted liver was shown to be a mature and functioning "human organ" that had zonal position-specific enzyme expression and a global gene expression pattern representative of mature human liver; and could generate a human-specific profile of drug metabolism. The 'humanized liver' could be stably maintained in these mice with a high level of synthetic function for a prolonged period (8 months). This novel in vivo system provides an optimized platform for studying human liver physiology, including drug metabolism, toxicology, or liver regeneration.
Collapse
Affiliation(s)
- Masami Hasegawa
- Biomedical Research Department, Central Institute for Experimental Animals, 1430 Nogawa, Miyamae, Kawasaki, Kanagawa 216-0001, Japan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Fabregat A, Pozo OJ, Marcos J, Segura J, Ventura R. Quantification of testosterone and metabolites released after alkaline treatment in human urine. Drug Test Anal 2010; 2:630-6. [DOI: 10.1002/dta.227] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2010] [Revised: 10/05/2010] [Accepted: 10/05/2010] [Indexed: 11/09/2022]
|
45
|
Pozo OJ, Van Eenoo P, Deventer K, Elbardissy H, Grimalt S, Sancho JV, Hernandez F, Ventura R, Delbeke FT. Comparison between triple quadrupole, time of flight and hybrid quadrupole time of flight analysers coupled to liquid chromatography for the detection of anabolic steroids in doping control analysis. Anal Chim Acta 2010; 684:98-111. [PMID: 21167991 DOI: 10.1016/j.aca.2010.10.045] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2010] [Revised: 09/28/2010] [Accepted: 10/31/2010] [Indexed: 11/18/2022]
Abstract
Triple quadrupole (QqQ), time of flight (TOF) and quadrupole-time of flight (QTOF) analysers have been compared for the detection of anabolic steroids in human urine. Ten anabolic steroids were selected as model compounds based on their ionization and the presence of endogenous interferences. Both qualitative and quantitative analyses were evaluated. QqQ allowed for the detection of all analytes at the minimum required performance limit (MRPL) established by the World Anti-Doping Agency (between 2 and 10 ng mL(-1) in urine). TOF and QTOF approaches were not sensitive enough to detect some of the analytes (3'-hydroxy-stanozolol or the metabolites of boldenone and formebolone) at the established MRPL. Although a suitable accuracy was obtained, the precision was unsatisfactory (RSD typically higher than 20%) for quantitative purposes irrespective of the analyser used. The methods were applied to 30 real samples declared positives either for the misuse of boldenone, stanozolol and/or methandienone. Most of the compounds were detected by every technique, however QqQ was necessary for the detection of some metabolites in a few samples. Finally, the possibility to detect non-target steroids has been explored by the use of TOF and QTOF. The use of this approach revealed that the presence of boldenone and its metabolite in one sample was due to the intake of androsta-1,4,6-triene-3,17-dione. Additionally, the intake of methandienone was confirmed by the post-target detection of a long-term metabolite.
Collapse
Affiliation(s)
- Oscar J Pozo
- DoCoLab, UGent, Department of Clinical Chemistry, Microbiology and Immunology, Technologiepark 30, B-9052 Zwijnaarde, Belgium.
| | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Bourcier S, Poisson C, Souissi Y, Kinani S, Bouchonnet S, Sablier M. Elucidation of the decomposition pathways of protonated and deprotonated estrone ions: application to the identification of photolysis products. RAPID COMMUNICATIONS IN MASS SPECTROMETRY : RCM 2010; 24:2999-3010. [PMID: 20872633 DOI: 10.1002/rcm.4722] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
With the future aim of elucidating the unknown structures of estrogen degradation products, we characterized the dissociation pathways of protonated estrone (E1) under collisional activation in liquid chromatography/tandem mass spectrometry (LC/MS/MS) experiments employing a quadrupole time-of-flight mass spectrometer. Positive ion and negative ion modes give information on the protonated and deprotonated molecules and their product ions. The mass spectra of estrone methyl ether (CH(3)-E1) and estrone-d(4) (E1-d(4)) were compared with that of E1 in order (i) to elucidate the dissociation mechanisms of protonated and deprotonated molecules and (ii) to propose likely structures for each product ions. The positive ion acquisition mode yielded more fragmentation. The mass spectra of E1 were compared with those of estradiol (E2), estriol (E3) and 17-ethynylestradiol (EE2). This comparison allowed the identification of marker ions for each ring of the estrogenic structure. Accurate mass measurements have been carried out for all the identified ions. The resulting ions revealed to be useful for the characterization of structural modifications induced by photolysis on each ring of the estrone molecule. These results are very promising for the determination of new metabolites in the environment.
Collapse
Affiliation(s)
- Sophie Bourcier
- Ecole Polytechnique et CNRS, Département de Chimie, Laboratoire des Mécanismes Réactionnels (DCMR), UMR 7651, 91128 Palaiseau Cedex, France.
| | | | | | | | | | | |
Collapse
|
47
|
Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test Anal 2010; 2:149-61. [DOI: 10.1002/dta.128] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
48
|
|
49
|
Pozo OJ, Lootens L, Van Eenoo P, Deventer K, Meuleman P, Leroux-Roels G, Parr MK, Schänzer W, Delbeke FT. Combination of liquid-chromatography tandem mass spectrometry in different scan modes with human and chimeric mouse urine for the study of steroid metabolism. Drug Test Anal 2009; 1:554-67. [DOI: 10.1002/dta.56] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
50
|
Ahi S, Beotra A, Jain S. Detection of mono-hydroxylated metabolites of stanozolol by HPLC-ESI (+) MS/MS in Indian sports persons. Drug Test Anal 2009; 1:538-44. [DOI: 10.1002/dta.76] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|